Table 5.
Pre-expansion | Post-expansion | Interaction P value | |||
---|---|---|---|---|---|
2008–2010 | 2014–2016 | ||||
N = 3887 | N = 4640 | ||||
No. of deaths | HR (95% CI) | No. of deaths | HR (95% CI) | ||
ACA status | .9745 | ||||
Expansion states | 689 | Reference | 601 | Reference | |
Non-expansion states | 2300 | 1.13 (1.03–1.23) | 2353 | 1.14 (1.04–1.26) | |
Sex | .2496 | ||||
Male | 1599 | Reference | 1635 | Reference | |
Female | 1390 | 1.00 (0.93–1.07) | 1319 | 0.94 (0.87–1.01) | |
Race | .489 | ||||
Non-Hispanic white | 2498 | Reference | 2438 | Reference | |
Non-Hispanic black | 140 | 0.89 (0.75–1.06) | 121 | 0.77 (0.64–0.92) | |
Non-Hispanic American Indian/Alaska Native | 5 | 0.48 (0.20–1.15) | 6 | 1.09 (0.49–2.44) | |
Non-Hispanic Asian or Pacific Islander | 103 | 0.75 (0.62–0.92) | 128 | 0.84 (0.70–1.01) | |
Hispanic (all races) | 235 | 0.97 (0.85–1.12) | 257 | 0.93 (0.82–1.07) | |
Non-Hispanic unknown race | 8 | 1.12 (0.55–2.28) | <5 | 0.69 (0.26–1.85) | |
Insurance status | .1665 | ||||
Uninsured | 19 | 0.79 (0.50–1.25) | 19 | 1.08 (0.68–1.70) | |
Any Medicaid | 227 | 0.94 (0.81–1.08) | 194 | 1.02 (0.87–1.19) | |
Non-Medicaid insured | 1983 | Reference | 2024 | Reference | |
Insured/No specifics | 648 | 1.01 (0.92–1.10) | 611 | 0.99 (0.90–1.08) | |
Insurance status unknown | 112 | 0.72 (0.59–0.89) | 106 | 1.03 (0.84–1.27) | |
Tumor size at diagnosis | .1577 | ||||
≤45 mm | 1237 | Reference | 1299 | Reference | |
>45 mm | 1208 | 1.25 (1.16–1.36) | 1203 | 1.15 (1.06–1.24) | |
Unknown | 544 | 1.07 (0.97–1.19) | 452 | 1.10 (0.98–1.23) |
Cox regression models stratified by radiation and adjusted for surgery and chemotherapy.
aAlaska (Natives), California, Connecticut, Georgia, Hawaii, Iowa, Kentucky, Louisiana, Michigan (Detroit), New Jersey, New Mexico, Utah, and Washington (Seattle).